The impact of DNMT3A variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemia
Abstract To refine the biological and prognostic significance of DNMT3A mutations in acute myeloid leukemia (AML), we assessed the impact of DNMT3A variant allele frequency (VAF) and its comutations in this study. Using targeted next‐generation sequencing, we analyzed 171 adult patients with de novo...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-05-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.5764 |
| _version_ | 1797817644022235136 |
|---|---|
| author | Xian Chen Chuchu Tian Zhuanghui Hao Lingang Pan Minglin Hong Wei Wei Daniel Muteb Muyey Hongwei Wang Xiuhua Chen |
| author_facet | Xian Chen Chuchu Tian Zhuanghui Hao Lingang Pan Minglin Hong Wei Wei Daniel Muteb Muyey Hongwei Wang Xiuhua Chen |
| author_sort | Xian Chen |
| collection | DOAJ |
| description | Abstract To refine the biological and prognostic significance of DNMT3A mutations in acute myeloid leukemia (AML), we assessed the impact of DNMT3A variant allele frequency (VAF) and its comutations in this study. Using targeted next‐generation sequencing, we analyzed 171 adult patients with de novo cytogenetically normal AML for DNMT3A mutations and associated comutations. DNMT3Amut was detected in 35 patients. DNMT3Amut patients were divided into DNMT3AHigh and DNMT3ALow using a cut‐off VAF value of 42%. We observed that DNMT3AHigh patients at diagnosis had increasing white blood cell (WBC) counts (p < 0.001) and a higher lactate dehydrogenase (LDH) level (p = 0.027), and were associated with lower complete remission (CR) rate (p = 0.015) and shorter overall survival (OS) (p = 0.032) than DNMT3ALow patients. We classified two different comutated genetypes, including DNMT3AmutNPM1mutFLT3‐ITDmut and DNMT3AmutIDH1/IDH2mut. Patients with DNMT3AmutNPM1mutFLT3‐ITDmut showed worse OS (p = 0.026) and relapse‐free survival (RFS) (p = 0.003) than those with DNMT3AmutIDH1/IDH2mut, and showed a shorter OS (p = 0.027) than those with DNMT3AwtNPM1mutFLT3‐ITDmut. We also observed that patients with DNMT3AmutIDH1/IDH2mut had higher platelet counts (p = 0.009) and a lower BM blast percentage (p = 0.040) than those with DNMT3AwtIDH1/IDH2mut. In multivariate analyses, DNMT3AHigh was independently associated with a lower CR rate (OR = 5.883; p = 0.004) and shorter OS (HR = 3.768; p < 0.001). DNMT3AmutNPM1mutFLT3‐ITDmut independently affected worse OS (HR = 6.030; p < 0.001) and RFS (HR = 8.939; p < 0.001). Our findings might be potentially useful for predicting clinical outcomes. |
| first_indexed | 2024-03-13T08:56:33Z |
| format | Article |
| id | doaj.art-88a768f1e89a44f196fb50c7c98c5e3b |
| institution | Directory Open Access Journal |
| issn | 2045-7634 |
| language | English |
| last_indexed | 2024-03-13T08:56:33Z |
| publishDate | 2023-05-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cancer Medicine |
| spelling | doaj.art-88a768f1e89a44f196fb50c7c98c5e3b2023-05-28T20:33:59ZengWileyCancer Medicine2045-76342023-05-01129103401035010.1002/cam4.5764The impact of DNMT3A variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemiaXian Chen0Chuchu Tian1Zhuanghui Hao2Lingang Pan3Minglin Hong4Wei Wei5Daniel Muteb Muyey6Hongwei Wang7Xiuhua Chen8Institute of Hematology The Second Hospital of Shanxi Medical University Taiyuan ChinaInstitute of Hematology The Second Hospital of Shanxi Medical University Taiyuan ChinaInstitute of Hematology The Second Hospital of Shanxi Medical University Taiyuan ChinaInstitute of Hematology The Second Hospital of Shanxi Medical University Taiyuan ChinaInstitute of Hematology The Second Hospital of Shanxi Medical University Taiyuan ChinaInstitute of Hematology The Second Hospital of Shanxi Medical University Taiyuan ChinaInstitute of Hematology The Second Hospital of Shanxi Medical University Taiyuan ChinaInstitute of Hematology The Second Hospital of Shanxi Medical University Taiyuan ChinaInstitute of Hematology The Second Hospital of Shanxi Medical University Taiyuan ChinaAbstract To refine the biological and prognostic significance of DNMT3A mutations in acute myeloid leukemia (AML), we assessed the impact of DNMT3A variant allele frequency (VAF) and its comutations in this study. Using targeted next‐generation sequencing, we analyzed 171 adult patients with de novo cytogenetically normal AML for DNMT3A mutations and associated comutations. DNMT3Amut was detected in 35 patients. DNMT3Amut patients were divided into DNMT3AHigh and DNMT3ALow using a cut‐off VAF value of 42%. We observed that DNMT3AHigh patients at diagnosis had increasing white blood cell (WBC) counts (p < 0.001) and a higher lactate dehydrogenase (LDH) level (p = 0.027), and were associated with lower complete remission (CR) rate (p = 0.015) and shorter overall survival (OS) (p = 0.032) than DNMT3ALow patients. We classified two different comutated genetypes, including DNMT3AmutNPM1mutFLT3‐ITDmut and DNMT3AmutIDH1/IDH2mut. Patients with DNMT3AmutNPM1mutFLT3‐ITDmut showed worse OS (p = 0.026) and relapse‐free survival (RFS) (p = 0.003) than those with DNMT3AmutIDH1/IDH2mut, and showed a shorter OS (p = 0.027) than those with DNMT3AwtNPM1mutFLT3‐ITDmut. We also observed that patients with DNMT3AmutIDH1/IDH2mut had higher platelet counts (p = 0.009) and a lower BM blast percentage (p = 0.040) than those with DNMT3AwtIDH1/IDH2mut. In multivariate analyses, DNMT3AHigh was independently associated with a lower CR rate (OR = 5.883; p = 0.004) and shorter OS (HR = 3.768; p < 0.001). DNMT3AmutNPM1mutFLT3‐ITDmut independently affected worse OS (HR = 6.030; p < 0.001) and RFS (HR = 8.939; p < 0.001). Our findings might be potentially useful for predicting clinical outcomes.https://doi.org/10.1002/cam4.5764acute myeloid leukemiaDNMT3A mutationsvariant allele frequency |
| spellingShingle | Xian Chen Chuchu Tian Zhuanghui Hao Lingang Pan Minglin Hong Wei Wei Daniel Muteb Muyey Hongwei Wang Xiuhua Chen The impact of DNMT3A variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemia Cancer Medicine acute myeloid leukemia DNMT3A mutations variant allele frequency |
| title | The impact of DNMT3A variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemia |
| title_full | The impact of DNMT3A variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemia |
| title_fullStr | The impact of DNMT3A variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemia |
| title_full_unstemmed | The impact of DNMT3A variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemia |
| title_short | The impact of DNMT3A variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemia |
| title_sort | impact of dnmt3a variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemia |
| topic | acute myeloid leukemia DNMT3A mutations variant allele frequency |
| url | https://doi.org/10.1002/cam4.5764 |
| work_keys_str_mv | AT xianchen theimpactofdnmt3avariantallelefrequencyandtwodifferentcomutationsonpatientswithdenovocytogeneticallynormalacutemyeloidleukemia AT chuchutian theimpactofdnmt3avariantallelefrequencyandtwodifferentcomutationsonpatientswithdenovocytogeneticallynormalacutemyeloidleukemia AT zhuanghuihao theimpactofdnmt3avariantallelefrequencyandtwodifferentcomutationsonpatientswithdenovocytogeneticallynormalacutemyeloidleukemia AT lingangpan theimpactofdnmt3avariantallelefrequencyandtwodifferentcomutationsonpatientswithdenovocytogeneticallynormalacutemyeloidleukemia AT minglinhong theimpactofdnmt3avariantallelefrequencyandtwodifferentcomutationsonpatientswithdenovocytogeneticallynormalacutemyeloidleukemia AT weiwei theimpactofdnmt3avariantallelefrequencyandtwodifferentcomutationsonpatientswithdenovocytogeneticallynormalacutemyeloidleukemia AT danielmutebmuyey theimpactofdnmt3avariantallelefrequencyandtwodifferentcomutationsonpatientswithdenovocytogeneticallynormalacutemyeloidleukemia AT hongweiwang theimpactofdnmt3avariantallelefrequencyandtwodifferentcomutationsonpatientswithdenovocytogeneticallynormalacutemyeloidleukemia AT xiuhuachen theimpactofdnmt3avariantallelefrequencyandtwodifferentcomutationsonpatientswithdenovocytogeneticallynormalacutemyeloidleukemia AT xianchen impactofdnmt3avariantallelefrequencyandtwodifferentcomutationsonpatientswithdenovocytogeneticallynormalacutemyeloidleukemia AT chuchutian impactofdnmt3avariantallelefrequencyandtwodifferentcomutationsonpatientswithdenovocytogeneticallynormalacutemyeloidleukemia AT zhuanghuihao impactofdnmt3avariantallelefrequencyandtwodifferentcomutationsonpatientswithdenovocytogeneticallynormalacutemyeloidleukemia AT lingangpan impactofdnmt3avariantallelefrequencyandtwodifferentcomutationsonpatientswithdenovocytogeneticallynormalacutemyeloidleukemia AT minglinhong impactofdnmt3avariantallelefrequencyandtwodifferentcomutationsonpatientswithdenovocytogeneticallynormalacutemyeloidleukemia AT weiwei impactofdnmt3avariantallelefrequencyandtwodifferentcomutationsonpatientswithdenovocytogeneticallynormalacutemyeloidleukemia AT danielmutebmuyey impactofdnmt3avariantallelefrequencyandtwodifferentcomutationsonpatientswithdenovocytogeneticallynormalacutemyeloidleukemia AT hongweiwang impactofdnmt3avariantallelefrequencyandtwodifferentcomutationsonpatientswithdenovocytogeneticallynormalacutemyeloidleukemia AT xiuhuachen impactofdnmt3avariantallelefrequencyandtwodifferentcomutationsonpatientswithdenovocytogeneticallynormalacutemyeloidleukemia |